• Citer

High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study

par Martiat, Philippe ;Ghilain, J M;Ferrant, Augustin;Doyen, C;Delannoy, André;Chatelain, Christian;Bosly, André;Michaux, Jean Louis;Sokal, G
Référence European journal of haematology, 45, 3, page (164-167)
Publication Publié, 1990-09

Article révisé par les pairs

• Détails
• Contenu

Titre:	High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study
Auteur:	Martiat, Philippe; Ghilain, J M; Ferrant, Augustin; Doyen, C; Delannoy, André; Chatelain, Christian; Bosly, André; Michaux, Jean Louis; Sokal, G
Informations sur la publication:	European journal of haematology, 45, 3, page (164-167)
Statut de publication:	Publié, 1990-09
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Amsacrine -- administration & dosage
	Amsacrine -- adverse effects
	Amsacrine -- therapeutic use
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Cytarabine -- administration & dosage
	Cytarabine -- adverse effects
	Cytarabine -- therapeutic use
	Female
	Humans
	Leukemia, Myeloid, Acute -- drug therapy
	Leukemia, Myeloid, Acute -- mortality
	Male
	Middle Aged
	Mitoxantrone -- administration & dosage
	Mitoxantrone -- adverse effects
	Mitoxantrone -- therapeutic use
	Prospective Studies
	Survival Rate
Note générale:	Clinical Trial
	Comparative Study
	Journal Article
	Randomized Controlled Trial
	FLWNA
Langue:	Anglais
Identificateurs:	urn:issn:0902-4441
	info:doi/10.1111/j.1600-0609.1990.tb00445.x
	info:pmid/2226729